Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1981-07-28
1985-05-14
Schwartz, Richard A.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
548333, A61K 31415, C07D23506
Patent
active
045173109
ABSTRACT:
The compound N-[2-hydroxy-2-(3-hydroxyphenyl)ethyl]-1H-benzimidazole-1-butanamine and methods for its manufacture and use are described herein. The compound is a cardiotonic agent useful primarily in the treatment of congestive heart failure.
REFERENCES:
patent: 3905990 (1975-09-01), Ehrmann et al.
Evans, D., et al., Pharmac. Ther. 16, 303 (1982).
Sonnenblick, E., et al., New Eng. J. Med., 300 (1), 17 (1979).
Diamond Julius
Wohl Ronald A.
Bellamy Elizabeth A.
Berlex Laboratories Inc.
Millen I. William
Schwartz Richard A.
White John L.
LandOfFree
N-[2-hydroxy-2-(3-hydroxyphenyl)ethyl]-1H-benzimidazole-1-butana does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with N-[2-hydroxy-2-(3-hydroxyphenyl)ethyl]-1H-benzimidazole-1-butana, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and N-[2-hydroxy-2-(3-hydroxyphenyl)ethyl]-1H-benzimidazole-1-butana will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-768946